Literature DB >> 16103329

Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.

Jeremy P Banky1, John W Kelly, Dallas R English, Josephine M Yeatman, John P Dowling.   

Abstract

OBJECTIVE: To determine the incidence of new, changed, and regressed nevi and melanomas in a cohort of patients at high risk for melanoma using baseline total body photography and dermatoscopy.
DESIGN: Cohort study of patients at high risk for melanoma who underwent baseline cutaneous photography between January 1, 1992, and December 31, 1997, and had at least 1 follow-up visit by December 31, 1998.
SETTING: Private practice rooms of 1 dermatologist in conjunction with a public hospital-based, multidisciplinary melanoma clinic in Victoria, Australia. PATIENTS: A total of 309 patients who had at least 1 of the following risk factors for melanoma: personal history, family history, 100 or more nevi, or 4 or more dysplastic nevi. MAIN OUTCOME MEASURES: Number of new, changed, and regressed nevi and melanomas detected and excised during the study interval.
RESULTS: The incidence of new, changed, and regressed nevi decreased with increasing age (P<.001), whereas the incidence of melanomas increased (P = .05). The number of dysplastic nevi at baseline was positively associated with the incidence of changed nevi (P<.001) and melanomas (P = .03). The use of baseline photography and dermatoscopy was associated with low biopsy rates and early detection of melanomas. The development of melanoma in association with a preexisting nevus was not directly correlated with a change in a preexisting lesion monitored by baseline photography.
CONCLUSIONS: Nevi are dynamic, and only a small percentage of all new and changed melanocytic lesions are melanomas. Patients younger than 50 years had a lower incidence of melanomas and a higher rate of new, changed, and regressed nevi when compared with patients older than 50 years. A new or changed pigmented lesion is more likely to be a melanoma in patients older than 50 years.

Entities:  

Mesh:

Year:  2005        PMID: 16103329     DOI: 10.1001/archderm.141.8.998

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  30 in total

Review 1.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

2.  Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma.

Authors:  Gabriel Salerni; Cristina Carrera; Louise Lovatto; Joan Anton Puig-Butille; Celia Badenas; Estel Plana; Susana Puig; Josep Malvehy
Journal:  J Am Acad Dermatol       Date:  2011-06-16       Impact factor: 11.527

Review 3.  New diagnostic aids for melanoma.

Authors:  Laura Korb Ferris; Ryan J Harris
Journal:  Dermatol Clin       Date:  2012-07       Impact factor: 3.478

Review 4.  Conceptual approach to early melanoma detection: models, tools, issues and challenges.

Authors:  Shadi Damanpour; James M Grichnik
Journal:  Melanoma Manag       Date:  2015-11-24

5.  Understanding visual search patterns of dermatologists assessing pigmented skin lesions before and after online training.

Authors:  Elizabeth A Krupinski; Joseph Chao; Rainer Hofmann-Wellenhof; Lynne Morrison; Clara Curiel-Lewandrowski
Journal:  J Digit Imaging       Date:  2014-12       Impact factor: 4.056

Review 6.  The study of nevi in children: Principles learned and implications for melanoma diagnosis.

Authors:  Alon Scope; Michael A Marchetti; Ashfaq A Marghoob; Stephen W Dusza; Alan C Geller; Jaya M Satagopan; Martin A Weinstock; Marianne Berwick; Allan C Halpern
Journal:  J Am Acad Dermatol       Date:  2016-06-17       Impact factor: 11.527

Review 7.  [Strategies for the noninvasive diagnosis of melanoma].

Authors:  C Fink; H A Haenssle
Journal:  Hautarzt       Date:  2016-07       Impact factor: 0.751

Review 8.  Screening and prevention measures for melanoma: is there a survival advantage?

Authors:  Clara Curiel-Lewandrowski; Suephy C Chen; Susan M Swetter
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

9.  Prevention of malignant melanoma.

Authors:  G Chaidemenos; A Stratigos; M Papakonstantinou; F Tsatsou
Journal:  Hippokratia       Date:  2008-01       Impact factor: 0.471

Review 10.  Current and emerging technologies in melanoma diagnosis: the state of the art.

Authors:  Estee L Psaty; Allan C Halpern
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.